334 related articles for article (PubMed ID: 18263685)
1. Detailed analysis of the radiographic presentation of Mycobacterium kansasii lung disease in patients with HIV infection.
Cattamanchi A; Nahid P; Marras TK; Gotway MB; Lee TJ; Gonzalez LC; Morris A; Webb WR; Osmond DH; Daley CL
Chest; 2008 Apr; 133(4):875-80. PubMed ID: 18263685
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings.
Fishman JE; Schwartz DS; Sais GJ
Radiology; 1997 Jul; 204(1):171-5. PubMed ID: 9205241
[TBL] [Abstract][Full Text] [Related]
3. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients.
El-Solh AA; Nopper J; Abdul-Khoudoud MR; Sherif SM; Aquilina AT; Grant BJ
Chest; 1998 Jul; 114(1):138-45. PubMed ID: 9674460
[TBL] [Abstract][Full Text] [Related]
4. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
Marras TK; Morris A; Gonzalez LC; Daley CL
Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152
[TBL] [Abstract][Full Text] [Related]
5. Clinical and radiological features of Mycobacterium kansasii and other NTM infections.
Matveychuk A; Fuks L; Priess R; Hahim I; Shitrit D
Respir Med; 2012 Oct; 106(10):1472-7. PubMed ID: 22850110
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium kansasii: a cause of treatable pulmonary disease associated with advanced human immunodeficiency virus (HIV) infection.
Levine B; Chaisson RE
Ann Intern Med; 1991 May; 114(10):861-8. PubMed ID: 1673053
[TBL] [Abstract][Full Text] [Related]
7. Cavitary lung lesions due to coinfection of Rhodococcus equi and Mycobacterium kansasii in a patient with acquired immunodeficiency syndrome.
Patel S; Wolf T
Am J Med; 2002 Jun; 112(8):678-80. PubMed ID: 12034423
[No Abstract] [Full Text] [Related]
8. Clinical manifestations and implications of coinfection with Mycobacterium kansasii and human immunodeficiency virus type 1.
Witzig RS; Fazal BA; Mera RM; Mushatt DM; Dejace PM; Greer DL; Hyslop NE
Clin Infect Dis; 1995 Jul; 21(1):77-85. PubMed ID: 7578764
[TBL] [Abstract][Full Text] [Related]
9. Mycobacterium kansasii infection in a Paris suburb: comparison of disease presentation and outcome according to human immunodeficiency virus status. Groupe dEtude Des Mycobactéries de la Seine-Saint-Denis.
Lortholary O; Deniel F; Boudon P; Le Pennec MP; Mathieu M; Soilleux M; Le Pendeven C; Loiseau P; Vincent V; Valeyre D
Int J Tuberc Lung Dis; 1999 Jan; 3(1):68-73. PubMed ID: 10094172
[TBL] [Abstract][Full Text] [Related]
10. [A comparison of chest radiographs between patients with pulmonary Mycobacterium kansasii infection and those with Mycobacterium tuberculosis infection in the initial stage of disease].
Inoue E; Senoo M; Nagayama N; Masuda K; Matsui H; Tamura A; Nagai H; Akagawa S; Toyoda E; Oota K
Kekkaku; 2013 Aug; 88(8):619-23. PubMed ID: 24044165
[TBL] [Abstract][Full Text] [Related]
11. Clinical and radiological features of Mycobacterium kansasii infection and Mycobacterium simiae infection.
Shitrit D; Peled N; Bishara J; Priess R; Pitlik S; Samra Z; Kramer MR
Respir Med; 2008 Nov; 102(11):1598-603. PubMed ID: 18619826
[TBL] [Abstract][Full Text] [Related]
12. Clinical, radiological and molecular features of Mycobacterium kansasii pulmonary disease.
Bakuła Z; Kościuch J; Safianowska A; Proboszcz M; Bielecki J; van Ingen J; Krenke R; Jagielski T
Respir Med; 2018 Jun; 139():91-100. PubMed ID: 29858008
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Shitrit D; Baum GL; Priess R; Lavy A; Shitrit AB; Raz M; Shlomi D; Daniele B; Kramer MR
Chest; 2006 Mar; 129(3):771-6. PubMed ID: 16537880
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with and poor prognostic factors for Mycobacterium kansasii-pulmonary disease.
Liu CJ; Huang HL; Cheng MH; Lu PL; Shu CC; Wang JY; Chong IW
Respir Med; 2019 May; 151():19-26. PubMed ID: 31047113
[TBL] [Abstract][Full Text] [Related]
15. [Infections with Mycobacterium kansasii in the Academic Medical Center in Amsterdam: the changing clinical spectrum since the start of the HIV epidemic].
van der Meer JT; Kerssemakers SP; van Steenwijk RP; Kuijper EJ
Ned Tijdschr Geneeskd; 1998 Apr; 142(17):965-9. PubMed ID: 9623171
[TBL] [Abstract][Full Text] [Related]
16. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
[TBL] [Abstract][Full Text] [Related]
17. Clinical Significance of Mycobacterium kansasii Isolates from Respiratory Specimens.
Moon SM; Park HY; Jeon K; Kim SY; Chung MJ; Huh HJ; Ki CS; Lee NY; Shin SJ; Koh WJ
PLoS One; 2015; 10(10):e0139621. PubMed ID: 26431540
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of Mycobacterium kansasii infection from Mycobacterium tuberculosis infection: comparison of clinical features, radiological appearance, and outcome.
Shitrit D; Priess R; Peled N; Bishara G; Shlomi D; Kramer MR
Eur J Clin Microbiol Infect Dis; 2007 Oct; 26(10):679-84. PubMed ID: 17629758
[TBL] [Abstract][Full Text] [Related]
19. Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study.
Geng E; Kreiswirth B; Burzynski J; Schluger NW
JAMA; 2005 Jun; 293(22):2740-5. PubMed ID: 15941803
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium kansasii and M. scrofulaceum isolates from HIV-negative South African gold miners: incidence, clinical significance and radiology.
Corbett EL; Hay M; Churchyard GJ; Herselman P; Clayton T; Williams BG; Hayes R; Mulder D; De Cock KM
Int J Tuberc Lung Dis; 1999 Jun; 3(6):501-7. PubMed ID: 10383063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
